Related Experiment Video
Updated: Jun 27, 2026

08:15
Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
Published on: January 31, 2020
Novel mouse models for understanding HIV-1 pathogenesis
Aviva Joseph1, Kaori Sango, Harris Goldstein
1Department of Microbiology, Albert Einstein College of Medicine, Bronx, NY, USA.
Methods in Molecular Biology (Clifton, N.J.)
|November 21, 2008
Summary
Developing small animal models for human immunodeficiency virus type 1 (HIV-1) infection is crucial for studying disease and screening therapies. New models offer improved research capabilities for HIV-1 pathogenesis and immune responses.
Area of Science:
- Immunology
- Virology
- Animal Models
Background:
- Studying human immunodeficiency virus type 1 (HIV-1) in vivo requires suitable animal models.
- Existing models like SCID-hu and huPBL-SCID have limitations.
- Advancements are needed for effective HIV-1 research and therapeutic development.
Purpose of the Study:
- To discuss the development and application of small animal models for in vivo HIV-1 studies.
- To explore new and existing models for HIV-1 infection, pathogenesis, and immune response research.
- To provide insights into the construction, maintenance, and infection protocols for these models.
Main Methods:
- Review of established severe combined immunodeficient (SCID)-hu models (thy/liv SCID-hu, huPBL-SCID).
- Introduction of novel models: intrasplenic huPBL/SPL-SCID, NOD/SCID/IL2Rgamma(null), and Rag2(-/-)gamma(c)(-/-) mice.
- Discussion of methodologies for model construction, maintenance, and HIV-1 infection.
Main Results:
- Detailed descriptions of three emerging small animal models for HIV-1 research.
- Comparison of the utility of various models in studying HIV-1 biology.
- Information on practical aspects of using these models for in vivo studies.
Conclusions:
- Small animal models are essential for advancing HIV-1 basic research and drug/vaccine screening.
- The newly emerged models offer enhanced capabilities for studying HIV-1 infection and immune responses.
- Further research and application of these models will accelerate progress in combating HIV-1.

